Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial

Authors

Document Type

Journal Article

Publication Date

8-10-2023

Journal

The Journal of infectious diseases

DOI

10.1093/infdis/jiad323

Keywords

SARS-CoV-2; Vaccine; Variant

Abstract

We compared the serologic responses of one versus two doses of a variant vaccine (Moderna mRNA-1273 Beta/Omicron BA.1 bivalent vaccine) in adults. A two-dose boosting regimen with a variant vaccine did not increase the magnitude or the durability of the serological responses compared to a single variant vaccine boost.

Department

Medicine

Share

COinS